Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$467M |
| 2 |
CRH
CRH
|
+$449M |
| 3 |
Broadcom
AVGO
|
+$446M |
| 4 |
Philip Morris
PM
|
+$414M |
| 5 |
Kenvue
KVUE
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$494M |
| 2 |
ExxonMobil
XOM
|
+$443M |
| 3 |
Visa
V
|
+$433M |
| 4 |
Merck
MRK
|
+$402M |
| 5 |
Advanced Micro Devices
AMD
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.89% |
| 2 | Healthcare | 11.83% |
| 3 | Financials | 11.72% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Coherus Oncology
CHRS
$217M
| $142K | ﹤0.01% |
38,086
-238,074
| -86% | -$1.1M |
|
3527
Kodiak Sciences
KOD
$2.5B
| $142K | ﹤0.01% |
78,715
+9,843
| +14% | +$34.7K |
|
|
DAO
3528
Youdao
DAO
$1.89B
| $142K | ﹤0.01% |
35,228
+881
| +3% | +$3.71K |
|
3529
Summit Therapeutics
SMMT
$10.2B
| $141K | ﹤0.01% |
75,599
+531
| +0.7% | +$1.01K |
|
3530
UroGen Pharma
URGN
$1.97B
| $141K | ﹤0.01% |
+10,055
| New | +$161K |
|
3531
KVH Industries
KVHI
$171M
| $140K | ﹤0.01% |
+27,476
| New | +$186K |
|
3532
GoodRx Holdings
GDRX
$1.09B
| $139K | ﹤0.01% |
24,718
-158,891
| -87% | -$1.06M |
|
3533
Crawford & Co Class A
CRD.A
$542M
| $136K | ﹤0.01% |
+14,521
| New | +$145K |
|
|
NIU
3534
Niu Technologies
NIU
$200M
| $135K | ﹤0.01% |
47,701
+1,195
| +3% | +$4.17K |
|
3535
The ONE Group
STKS
$55.9M
| $134K | ﹤0.01% |
+24,409
| New | +$166K |
|
3536
Westrock Coffee
WEST
$798M
| $134K | ﹤0.01% |
15,102
-410
| -3% | -$4.27K |
|
3537
Toro Corp
TORO
$175M
| $133K | ﹤0.01% |
22,809
+192
| +0.8% | +$1.02K |
|
3538
Arcutis Biotherapeutics
ARQT
$3.48B
| $133K | ﹤0.01% |
25,073
-246
| -1% | -$2.09K |
|
3539
NerdWallet
NRDS
$632M
| $133K | ﹤0.01% |
14,922
| – | – |
|
|
LTRPA
3540
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $132K | ﹤0.01% |
270,528
+2,160
| +0.8% | +$1.4K |
|
3541
Edgewise Therapeutics
EWTX
$4.28B
| $132K | ﹤0.01% |
22,975
+11,252
| +96% | +$76.5K |
|
3542
Compass Therapeutics
CMPX
$349M
| $130K | ﹤0.01% |
66,096
+27,452
| +71% | +$67.9K |
|
3543
Playboy Inc
PLBY
$136M
| $129K | ﹤0.01% |
161,043
+1,296
| +0.8% | +$1.86K |
|
|
AGEN
3544
Agenus
AGEN
$276M
| $129K | ﹤0.01% |
5,699
+361
| +7% | +$10.2K |
|
3545
Inovio Pharmaceuticals
INO
$85.6M
| $129K | ﹤0.01% |
27,540
+1,708
| +7% | +$9.43K |
|
3546
Domo
DOMO
$171M
| $128K | ﹤0.01% |
13,092
+105
| +0.8% | +$1.46K |
|
|
NXDR
3547
Nextdoor Holdings
NXDR
$885M
| $128K | ﹤0.01% |
70,514
+2,165
| +3% | +$5.36K |
|
|
OPTU
3548
Optimum Communications Inc
OPTU
$298M
| $128K | ﹤0.01% |
39,186
-312,633
| -89% | -$1.01M |
|
|
TGB
3549
Trekor Metals
TGB
$2.45B
| $126K | ﹤0.01% |
99,065
-3,011
| -3% | -$4.17K |
|
3550
Grindr
GRND
$3.06B
| $120K | ﹤0.01% |
20,942
| – | – |
|
Similar funds
Invesco's Q3 2023 Portfolio in Review
As of Q3 2023, Invesco held 3,966 positions worth $371B, down 2.7% from $381B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Invesco's Q3 2023 filing shows 118 new, 2,175 increased, 1,355 reduced and 98 closed positions. Its largest new stake was Stellantis: 12,130,006 shares worth $232M. The largest sale was Microsoft, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q3 2023 buy was Stellantis: 12,130,006 shares worth $232M.
- Invesco added most to Adobe in Q3 2023, an estimated $467M increase.
- Invesco's biggest Q3 2023 reduction was Microsoft, cutting an estimated $494M.
- Invesco fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $272M.
- Invesco's ten largest holdings make up 14% of its $371B portfolio in Q3 2023.
- Invesco opened 118 new positions and closed 98 in Q3 2023.
- Invesco's portfolio value fell 2.7% quarter-over-quarter to $371B.
Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.